financetom
Business
financetom
/
Business
/
Bank of Montreal Fiscal Q3 Adjusted Earnings Decrease, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bank of Montreal Fiscal Q3 Adjusted Earnings Decrease, Revenue Rises
Aug 29, 2024 2:40 AM

06:08 AM EDT, 08/27/2024 (MT Newswires) -- Bank of Montreal ( BERZ ) reported fiscal Q3 adjusted earnings Tuesday of 2.64 Canadian dollars ($1.96) per diluted share, down from CA$2.94 a year earlier.

Analysts polled by Capital IQ expected CA$2.76.

Revenue for the quarter ended July 31 was CA$8.19 billion, up from CA$8.05 billion a year earlier.

Analysts polled by Capital IQ expected CA$8.24 billion.

The company maintained a quarterly dividend of CA$1.55 per share, payable Nov. 26 to shareholders of record on Oct. 30.

Price: 87.80, Change: -0.97, Percent Change: -1.09

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nucor to Acquire Rytec for $565 Million
Nucor to Acquire Rytec for $565 Million
Jun 3, 2024
10:11 AM EDT, 06/03/2024 (MT Newswires) -- Nucor ( NUE ) said Monday it agreed to acquire Rytec, which manufactures commercial doors, through an all-cash, $565 million transaction. Nucor ( NUE ) Chief Executive Officer Leon Topalian said the acquisition is in line with the company's strategy of expanding beyond its core steelmaking businesses and into related downstream businesses. Price:...
Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study
Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study
Jun 3, 2024
10:08 AM EDT, 06/03/2024 (MT Newswires) -- Genmab ( GMAB ) said Monday that its antibody-drug conjugate tisotumab vedotin showed encouraging antitumor activity as a monotherapy in a phase 2 trial in patients with head and neck squamous cell carcinoma which progressed on or after first-line treatment. Citing phase 2 data, the company said 32.5% of patients achieved a confirmed...
What's Going On With Bio-Path Stock?
What's Going On With Bio-Path Stock?
Jun 3, 2024
Bio-Path Holdings, Inc. ( BPTH ) shares are trading higher Monday after the company announced the presentation of interim results from its Phase 2 study of prexigebersen (BP1001) in combination with decitabine and venetoclax for the treatment of acute myeloid leukemia (AML).   The Details: The company presented data on Saturday which showed prexigebersen to be well-tolerated and has demonstrated efficacy...
Roaring Kitty's Return: What's Going On With Reddit Stock?
Roaring Kitty's Return: What's Going On With Reddit Stock?
Jun 3, 2024
Reddit Inc ( RDDT ) shares are trading higher Monday after an account associated with GameStop Corp ( GME ) trader Keith Gill posted on the platform for the first time in three years.  What Happened: Gill, best known as Roaring Kitty on YouTube and X or DeepF***ingValue on Reddit ( RDDT ), posted a screenshot to Reddit ( RDDT ) suggesting...
Copyright 2023-2026 - www.financetom.com All Rights Reserved